Skip to content

Viability Scan Hyderabad | Focus Diagnostics

VIABILITY SCAN

Get reliable diagnostics, expert support, and a seamless booking experience with Focus Diagnostics.

PriceRs. 29500
Book Now

About this test

What is a Myocardial Viability Scan?

A Myocardial Viability Scan is a specialised nuclear medicine cardiac investigation used to assess whether heart muscle tissue is alive and potentially capable of recovering its function. The myocardium is the muscular tissue responsible for pumping blood throughout the body. When blood supply to the heart is reduced because of coronary artery disease or a previous heart attack, some areas of the heart muscle may become weakened. However, not all weakened heart muscle is permanently damaged. Some tissue may remain viable despite having reduced blood supply. This condition is sometimes described as hibernating myocardium. A myocardial viability investigation uses radioactive tracers and nuclear imaging techniques to evaluate tracer uptake and distribution within the heart muscle. Depending on the imaging protocol, commonly used tracers include Thallium-201 or Technetium-99m-labelled radiopharmaceuticals. The images are acquired using specialised nuclear medicine equipment and help doctors assess myocardial viability and guide further cardiac management.

Why is a Myocardial Viability Scan recommended?

A doctor may recommend a Myocardial Viability Scan for patients with coronary artery disease, previous myocardial infarction or reduced left ventricular function. When the heart muscle is weakened, it is important to understand whether the affected areas contain viable tissue or permanent scar tissue. The investigation helps assess whether dysfunctional heart muscle may have the potential to recover following restoration of blood supply. The findings may assist cardiologists and cardiac surgeons when considering treatment options such as coronary angioplasty, stenting or coronary artery bypass graft surgery. The scan is particularly useful in selected patients with impaired heart pumping function and suspected hibernating myocardium.

What conditions can a Myocardial Viability Scan help evaluate?

A Myocardial Viability Scan may support the evaluation of coronary artery disease, previous heart attack, reduced left ventricular function and suspected hibernating myocardium. It helps assess areas of reduced myocardial perfusion and distinguish potentially viable heart muscle from areas that may represent permanent scar tissue. It may also contribute to the evaluation of patients with ischaemic cardiomyopathy and impaired cardiac pumping function. The findings are interpreted alongside echocardiography, ECG, coronary angiography, cardiac MRI and other relevant investigations. A viability scan does not independently determine the need for cardiac surgery or guarantee improvement in heart function after treatment.

How is a Myocardial Viability Scan performed?

The investigation is performed in a nuclear medicine department using specialised cardiac imaging equipment. A suitable radioactive tracer is administered intravenously according to the selected imaging protocol. Commonly used radiopharmaceuticals for myocardial viability assessment include Thallium-201 and Technetium-99m-labelled tracers such as sestamibi. The tracer distribution within the heart muscle is detected using a gamma camera, often with SPECT imaging. Images may be acquired at different time points depending on the tracer and protocol. Some examinations use redistribution or delayed imaging to assess changes in tracer uptake over time. The nuclear medicine specialist reviews the myocardial images and evaluates the distribution of tracer uptake to assess the viability of different heart muscle regions.

Preparation before a Myocardial Viability Scan

Preparation depends on the radiotracer and the specific cardiac imaging protocol. Patients may be asked to fast for a specified period before the investigation. Medication instructions vary depending on whether the examination includes rest imaging, stress imaging or a specialised viability protocol. Patients should inform the medical team about their cardiac history, previous heart attacks, coronary procedures, current medications, allergies and any previous nuclear medicine examinations. Patients should also inform the department about pregnancy or breastfeeding where applicable. Do not stop prescribed heart medications without medical advice. Follow the specific fasting, medication and appointment instructions provided by Focus Diagnostics.

Understanding the Myocardial Viability Scan Report

The report describes the distribution and intensity of radiotracer uptake within different regions of the heart muscle. Preserved tracer uptake generally suggests viable myocardial tissue, while persistently reduced or absent uptake may suggest scar tissue or non-viable myocardium, depending on the tracer and imaging protocol. Some areas may demonstrate reduced initial uptake followed by improved uptake on delayed or redistribution images, suggesting retained viability. The report may also describe regional perfusion abnormalities and the extent of affected myocardial tissue. Results should be interpreted alongside cardiac function measurements, coronary anatomy, clinical symptoms and other cardiac investigations. The findings help doctors assess treatment options but cannot independently predict an individual patient's recovery.

Benefits of a Myocardial Viability Scan

A Myocardial Viability Scan provides functional information about the condition of heart muscle tissue. It helps identify areas of potentially viable myocardium and areas that may contain permanent damage. This information can support treatment planning in selected patients with coronary artery disease and reduced heart pumping function. The investigation provides regional information about myocardial tracer uptake and may help doctors assess whether further revascularisation evaluation is appropriate. It complements other cardiac investigations and contributes to a more comprehensive assessment of heart function.

Who should undergo a Myocardial Viability Scan?

A Myocardial Viability Scan may be recommended for patients with a previous heart attack, coronary artery disease, reduced ejection fraction or weakened heart muscle when assessment of myocardial viability is clinically required. It may also be considered for selected patients with ischaemic cardiomyopathy who are being evaluated for coronary revascularisation. The treating cardiologist determines whether this investigation is appropriate based on the patient's symptoms, cardiac function, coronary anatomy and previous test results.

Is a Myocardial Viability Scan safe?

A Myocardial Viability Scan is a diagnostic nuclear medicine procedure involving a controlled amount of radioactive tracer. Radiation exposure depends on the radiopharmaceutical, administered activity and imaging protocol. The examination is performed under established nuclear medicine safety procedures. Some patients may experience temporary discomfort associated with intravenous injection. Patients should inform the medical team about pregnancy, breastfeeding, allergies and existing medical conditions before the examination. The nuclear medicine specialist will provide appropriate safety instructions according to the selected tracer and individual patient requirements.

Difference between Myocardial Perfusion Scan and Myocardial Viability Scan

A Myocardial Perfusion Scan primarily evaluates blood flow to the heart muscle, often comparing images acquired during rest and stress conditions. A Myocardial Viability Scan focuses on determining whether weakened or poorly perfused heart muscle tissue remains alive and may have the potential to recover function. Both investigations use nuclear medicine techniques and may share some radiotracers, but their imaging protocols and clinical objectives differ. The cardiologist selects the appropriate examination according to the patient's cardiac condition and diagnostic requirements.

Myocardial Viability Scan at Focus Diagnostics, Hyderabad

Focus Diagnostics provides specialised diagnostic imaging and nuclear medicine services in Hyderabad, Telangana. The Myocardial Viability Scan supports the evaluation of heart muscle tissue in patients with suspected coronary artery disease, previous myocardial infarction and reduced cardiac function. Using gamma camera-based nuclear imaging, the investigation helps assess regional tracer uptake and myocardial viability. If your cardiologist has recommended a Myocardial Viability Scan, contact Focus Diagnostics to confirm the available radiotracer protocol, scan availability, preparation requirements, appointment scheduling and expected reporting time.

Test FAQs

What is a Myocardial Viability Scan?

A Myocardial Viability Scan is a nuclear medicine cardiac investigation that evaluates whether weakened heart muscle tissue remains alive and potentially capable of recovering its function.

Why is a Myocardial Viability Scan recommended?

It may be recommended for patients with coronary artery disease, previous heart attacks or reduced heart pumping function to assess the viability of affected heart muscle.

What does a Myocardial Viability Scan detect?

It evaluates radiotracer uptake within the heart muscle to help distinguish potentially viable myocardium from areas that may contain permanent scar tissue.

Can a Myocardial Viability Scan detect heart muscle damage?

It can help identify areas with reduced or absent tracer uptake that may indicate myocardial damage or scar tissue. Findings require correlation with other cardiac investigations.

Which radioactive tracer is used for a Myocardial Viability Scan?

Depending on the imaging protocol, tracers may include Thallium-201 or Technetium-99m-labelled radiopharmaceuticals such as sestamibi.

Is fasting required before a Myocardial Viability Scan?

Fasting requirements depend on the selected radiotracer and examination protocol. Follow the specific instructions provided by the nuclear medicine department.

Can a Myocardial Viability Scan help after a heart attack?

Yes. It may help assess whether affected heart muscle contains viable tissue or areas of permanent damage following a previous myocardial infarction.

What is hibernating myocardium?

Hibernating myocardium refers to weakened heart muscle that has reduced blood supply but remains viable and may improve its function after appropriate restoration of blood flow.

What is the difference between a Myocardial Perfusion Scan and a Viability Scan?

A perfusion scan evaluates blood flow to the heart muscle, while a viability scan focuses on determining whether weakened heart muscle remains alive and potentially capable of functional recovery.

Is a Myocardial Viability Scan safe?

It is a diagnostic nuclear medicine investigation performed using a controlled quantity of radioactive tracer. The medical team provides appropriate radiation safety instructions.

Where can I get a Myocardial Viability Scan in Hyderabad?

You can contact Focus Diagnostics, Hyderabad, to enquire about Myocardial Viability Scan availability, radiotracer protocol, appointment scheduling and preparation instructions.

VIABILITY SCAN

Rs. 29500

Book

Where this gamma camera scan is done in Hyderabad

All nuclear medicine tests and prices in Hyderabad

Explore Related Tests & Services

Find Your Nearest Focus Diagnostic Centre Hyderabad

Popular Lab Tests in Other Cities

Book Your lab tests instantly

Accurate reports and home sample collection across Hyderabad

Book on Whatsapp